Research map: Coordinated microbial-inflammatory associations in never-smoking lung cancer

Papers in this map

1. Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening · The National Lung Screening Trial Research Team · 2011 · 11268 citations · Cited by this paper
2. Epiproteomic profiling identifies histone H4 hyperacetylation as a prognostic marker in pleural mesothelioma · 2026 · Related
3. Chronic Inflammation and Cytokines in the Tumor Microenvironment · Glauben Landskron · 2014 · 1793 citations · Cited by this paper
4. Neoadjuvant and perioperative chemo-immunotherapy in early-stage non-small cell lung cancer: international expert panel meeting by AIOT · 2026 · Related
5. Lung Cancer Incidence in Never Smokers · Heather A. Wakelee · 2007 · 626 citations · Cited by this paper
6. BRAF fusions define therapeutic vulnerability and tyrosine kinase inhibitor resistance in non-small cell lung cancer · 2026 · Related
7. Airway Microbiota Is Associated with Upregulation of the PI3K Pathway in Lung Cancer · Jun-Chieh James Tsay · 2018 · 473 citations · Cited by this paper
8. Real-world burden of cardiovascular events following immune checkpoint inhibitor therapy: impact on mortality and treatment resumption in 29,503 patients · 2026 · Related
9. Plasma microRNAs as potential biomarkers for non-small-cell lung cancer · Jun Shen · 2010 · 389 citations · Cited by this paper
10. Biology, detection, and management of incidental pulmonary nodules: the emerging role of targeted treatments. A review of the current literature and future perspectives · 2026 · Related
11. Increased Levels of Circulating Interleukin 6, Interleukin 8, C-Reactive Protein, and Risk of Lung Cancer · Sharon R. Pine · 2011 · 338 citations · Cited by this paper
12. Efficacy and safety of immune checkpoint inhibitors in lung cancer patients with hepatitis B surface antigen positivity: a real-world cohort study · 2026 · Related
13. Lower Airway Dysbiosis Affects Lung Cancer Progression · Jun-Chieh J. Tsay · 2020 · 318 citations · Cited by this paper
14. Time-dependent bias in local consolidative therapy for EGFR-mutant metastatic non-small cell lung cancer · 2026 · Related
15. IL8, Neutrophils, and NETs in a Collusion against Cancer Immunity and Immunotherapy · Álvaro Teijeira · 2020 · 297 citations · Cited by this paper
16. Clonal divergence with acquired BRAF V600E in NSCLC with compound EGFR G719X/S768I after prolonged EGFR-TKI therapy · 2026 · Related
17. Diagnosis of lung cancer in individuals with solitary pulmonary nodules by plasma microRNA biomarkers · Jun Shen · 2011 · 253 citations · Cited by this paper
18. CT surveillance, patterns of recurrence and eligibility for salvage therapy after curative intent treatment for unresectable stage III non small cell lung cancer · 2026 · Related
19. Lung cancer in never smokers—the East Asian experience · Fei Zhou · 2018 · 208 citations · Cited by this paper
20. First-line treatment for unresectable pulmonary lymphoepithelial carcinoma: A real-world comparison of platinum-based doublet chemotherapy with or without PD-1 inhibitors · 2026 · Related
21. The Role of Tumor Inflammatory Microenvironment in Lung Cancer · Zhaofeng Tan · 2021 · 207 citations · Cited by this paper
22. Proportion of Never-Smoker Non–Small Cell Lung Cancer Patients at Three Diverse Institutions · Lorraine Cheryl Pelosof · 2016 · 188 citations · Cited by this paper
23. A plasma miRNA signature for lung cancer early detection · Qixin Leng · 2017 · 63 citations · Cited by this paper
24. A Plasma Long Noncoding RNA Signature for Early Detection of Lung Cancer · Yanli Lin · 2018 · 60 citations · Cited by this paper
25. The mutagenic forces shaping the genomes of lung cancer in never smokers · Marcos Díaz‐Gay · 2025 · 58 citations · Cited by this paper
26. Streptococcus pneumoniae promotes lung cancer development and progression · Ning Li · 2023 · 51 citations · Cited by this paper
27. Long-term Survival Outcomes by Smoking Status in Surgical and Nonsurgical Patients With Non-small Cell Lung Cancer · Robert A. Meguid · 2010 · 47 citations · Cited by this paper
28. A Direct Plasma miRNA Assay for Early Detection and Histological Classification of Lung Cancer · Qixin Leng · 2018 · 24 citations · Cited by this paper
29. Profiling Plasma Cytokines by A CRISPR-ELISA Assay for Early Detection of Lung Cancer · Ning Li · 2022 · 21 citations · Cited by this paper
30. Circulating Bacterial DNA as Plasma Biomarkers for Lung Cancer Early Detection · Huifen Zhou · 2023 · 18 citations · Cited by this paper
31. Systematic assessment of the clinicopathological prognostic significance of tissue cytokine expression for lung adenocarcinoma based on integrative analysis of TCGA data · Yuanmei Dong · 2019 · 15 citations · Cited by this paper
32. Respiratory Tract Oncobiome in Lung Carcinogenesis: Where Are We Now? · Karolina H. Czarnecka · 2023 · 9 citations · Cited by this paper
33. Cost-effectiveness of low-dose CT screening for non-smokers with a first-degree relative history of lung cancer · Yin Liu · 2025 · 7 citations · Cited by this paper
34. Cytokine Signatures for Lung Cancer Diagnosis in African American Populations · Qixin Leng · 2024 · 5 citations · Cited by this paper
35. Integrative Biomarker Panel for Improved Lung Cancer Diagnosis Using Plasma microRNAs and Sputum Bacterial DNA · Pushpa Dhilipkannah · 2024 · 5 citations · Cited by this paper
36. Improving CT scan for lung cancer diagnosis with an integromic signature · Jipei Liao · 2024 · 3 citations · Cited by this paper
37. Efficacy of Vinorelbine in the Second-Line Setting and Beyond in Non-small Cell Lung Cancer · Janakiraman Subramanian · 2007 · 2 citations · Cited by this paper
38. Impact of Chronic Lung Disease, Socioeconomic Status, and Family History on Lung Cancer Risk in People Who Have Never Smoked · Hyun Seok Kwak · 2025 · 2 citations · Cited by this paper
39. Streptococcus pneumoniae infection is associated with matrix metalloproteinase-9 in lung cancer progression and brain metastases · Lu Gao · 2025 · 1 citation · Cited by this paper

Source: OpenAlex (CC0)